Bucaretchi F, Miglioli L, Baracat E C, Madureira P R, Capitani E M, Vieira R J
Centro de Controle de Intoxicações-FCM-UNICAMP, Campinas, SP, Brazil.
J Pediatr (Rio J). 2000 Jul-Aug;76(4):290-4. doi: 10.2223/jped.9.
To study the changes in methemoglobinemia of 17 children admitted with acute exposure to dapsone complicated by a methemoglobin concentration greater than 20% of the total hemoglobin. The children were treated with multiple doses of activated charcoal with or without the administration of methylene blue.PATIENTS AND METHODS: Seventeen patients (ages 1-13 y, median 3 y), were admitted 1-72 h after the ingestion of 100-1200 mg (median 350 mg, 10 patients) or an unknown amount of dapsone (7 patients). The methemoglobin blood concentrations upon admission ranged from 23.5%-49.7% (median 37.8%), and the main clinical features were cyanosis (17), tachycardia (17), vomiting (11) and tachypnea (8). All of the children received multiple doses of activated charcoal orally or via nasogastric tube (1g/kg, 10% solution, 4-6 times/day, 3-16 doses with a median of 8 doses). Twelve of the 14 patients with methemoglobin levels greater than 30% were also treated with a single dose of methylene blue (1-2% solution, 1-2 mg/kg) infused IV over 5 min.RESULTS: There was a progressive decrease in the methemoglobin levels after the beginning of both treatments (multiple doses of activated charcoal alone or associated with methylene blue), and only one dose of methylene blue was necessary. There were no significant statistical differences between the results of the two treatments according to the time-course decrease in methemoglobinemia (p=0.49 Wilcoxon test).CONCLUSIONS: Multiple doses of activated charcoal given when methemoglobin levels were greater than 20% can be considered as a possible treatment for pediatric patients, with or without the administration of methylene blue, after acute dapsone exposure.
研究17例急性接触氨苯砜且高铁血红蛋白浓度超过总血红蛋白20%的儿童高铁血红蛋白血症的变化情况。这些儿童接受了多剂量活性炭治疗,部分同时给予亚甲蓝。
17例患者(年龄1 - 13岁,中位数3岁),在摄入100 - 1200 mg(中位数350 mg,10例患者)或未知剂量氨苯砜(7例患者)后1 - 72小时入院。入院时高铁血红蛋白血浓度范围为23.5% - 49.7%(中位数37.8%),主要临床特征为发绀(17例)、心动过速(17例)、呕吐(11例)和呼吸急促(8例)。所有儿童均经口服或鼻胃管接受多剂量活性炭治疗(1 g/kg,10%溶液,每日4 - 6次,3 - 16剂,中位数8剂)。14例高铁血红蛋白水平大于30%的患者中有12例还接受了单次静脉注射亚甲蓝(1 - 2%溶液,1 - 2 mg/kg,5分钟内输注完毕)。
两种治疗方法(单独使用多剂量活性炭或联合亚甲蓝)开始后,高铁血红蛋白水平均逐渐下降,且仅需一剂亚甲蓝。根据高铁血红蛋白血症的时间进程下降情况,两种治疗结果之间无显著统计学差异(Wilcoxon检验,p = 0.49)。
对于急性接触氨苯砜后高铁血红蛋白水平大于20%的儿科患者,无论是否给予亚甲蓝,给予多剂量活性炭均可作为一种可能的治疗方法。